BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 8033117)

  • 1. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia.
    Zhang SJ; Ma LY; Huang QH; Li G; Gu BW; Gao XD; Shi JY; Wang YY; Gao L; Cai X; Ren RB; Zhu J; Chen Z; Chen SJ
    Proc Natl Acad Sci U S A; 2008 Feb; 105(6):2076-81. PubMed ID: 18250304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chronic myeloid leukemia present with an unusual relapse in central nervous system: A case report.
    Musleh M; Alhussien Q
    Clin Case Rep; 2024 Apr; 12(4):e8671. PubMed ID: 38550723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia.
    Menezes J; Salgado RN; Acquadro F; Gómez-López G; Carralero MC; Barroso A; Mercadillo F; Espinosa-Hevia L; Talavera-Casañas JG; Pisano DG; Alvarez S; Cigudosa JC
    Blood Cancer J; 2013 Nov; 3(11):e157. PubMed ID: 24212482
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations.
    Curik N; Laznicka A; Polivkova V; Krizkova J; Pokorna E; Semerak P; Suchankova P; Burda P; Hochhaus A; Machova Polakova K
    Leukemia; 2024 Apr; ():. PubMed ID: 38615117
    [No Abstract]   [Full Text] [Related]  

  • 5. Report of chronic myeloid leukemia from SEAROC experience, Jaipur over a period of 9 years.
    Maru A
    Indian J Med Paediatr Oncol; 2013 Jul; 34(3):180-1. PubMed ID: 24516304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients.
    Geissler K; Jäger E; Barna A; Gurbisz M; Graf T; Graf E; Nösslinger T; Pfeilstöcker M; Tüchler H; Sliwa T; Keil F; Geissler C; Heibl S; Thaler J; Machherndl-Spandl S; Zach O; Weltermann A; Bettelheim P; Stauder R; Zebisch A; Sill H; Schwarzinger I; Schneeweiss B; Öhler L; Ulsperger E; Kusec R; Germing U; Sperr WR; Knöbl P; Jäger U; Hörmann G; Valent P
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic myeloid leukemia extramedullary blast crisis presenting as central nervous system leukemia: A case report.
    Jin M; Xuan C; Gao J; Han R; Xu S; Wang L; Wang Y; Shi K; Rauniyar S; An Q
    Medicine (Baltimore); 2018 Nov; 97(45):e13131. PubMed ID: 30407337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the 'cerebral diabetes paradigm'.
    Brewer JK
    J Mol Neurosci; 2008 Jul; 35(3):307-22. PubMed ID: 18563304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microRNAs involved in human myeloid differentiation and myelogenous/myeloblastic leukemia.
    Wang XS; Zhang JW
    J Cell Mol Med; 2008; 12(5A):1445-55. PubMed ID: 18554315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant disease.
    Yoshida C; Melo JV
    Int J Hematol; 2004 Jun; 79(5):420-33. PubMed ID: 15239391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High sequence similarity within ras exons 1 and 2 in different mammalian species and phylogenetic divergence of the ras gene family.
    Watzinger F; Mayr B; Haring E; Lion T
    Mamm Genome; 1998 Mar; 9(3):214-9. PubMed ID: 9501305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
    Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
    Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies].
    Kurosawa M
    Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms in the evolution of chronic myelocytic leukemia.
    Cline MJ; Jat PS; Foti A
    Leuk Lymphoma; 1992 Jul; 7(4):283-7. PubMed ID: 1493427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of p53 in leukemogenesis of chronic myeloid leukemia.
    Lanza F; Bi S
    Stem Cells; 1995 Jul; 13(4):445-52. PubMed ID: 7549904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
    Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
    Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.